8-K
Current Report
SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-096645
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading sabs-20250717.htm…